Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Astec Lifesciences Limited ( (IN:ASTEC) ) has provided an update.
Astec LifeSciences Limited has announced the re-appointment of Mr. Nandkumar Dhekne as a Non-Executive & Independent Director for a second term of five years, starting from December 18, 2025, to December 17, 2030, pending shareholder approval. This decision, based on the Nomination and Remuneration Committee’s recommendation, highlights the company’s commitment to maintaining experienced leadership, as Mr. Dhekne brings extensive expertise in operations management and sales across the Asia Pacific region, which could positively impact the company’s strategic direction and stakeholder confidence.
More about Astec Lifesciences Limited
Astec LifeSciences Limited operates in the chemical industry, focusing on the production of agrochemical active ingredients and pharmaceutical intermediates. The company is known for its expertise in the development and manufacturing of a wide range of products that cater to the agricultural sector, enhancing crop protection and yield.
Average Trading Volume: 2,086
Technical Sentiment Signal: Sell
Current Market Cap: 17.93B INR
See more insights into ASTEC stock on TipRanks’ Stock Analysis page.